Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
World Neurosurgery|February 22, 2021
Foundations of Neuro-Oncology: A Multidisciplinary ApproachMarissa Barbaro, Howard A Fine, Rajiv S Magge
Cornea|June 11, 2009
Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytomaSteven Yeh, Howard A Fine, Janine A Smith
World Neurosurgery|July 10, 2021
Innovations in Neuro-OncologyRajiv S Magge, Marissa Barbaro, Howard A Fine
Cancer Informatics|January 10, 2015
Correction to "master regulators, regulatory networks, and pathways of glioblastoma subtypes"Serdar Bozdag, Aiguo Li, Mehmet Baysan, et al.
Bioinformatics (Oxford, England)|June 2, 2010
FastMEDUSA: a parallelized tool to infer gene regulatory networksSerdar Bozdag, Aiguo Li, Stefan Wuchty, et al.
Neoplasia (New York, N.Y.)|June 26, 2002
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vectorJeongwu Lee, Monika Hampl, Paul Albert, et al.
Journal of Neuro-Oncology|March 28, 2012
Refining endpoints in brain tumor clinical trialsChristina A Meyers, Edwin P Rock, Howard A Fine
Cancer Informatics|November 5, 2014
Master regulators, regulatory networks, and pathways of glioblastoma subtypesSerdar Bozdag, Aiguo Li, Mehmet Baysan, et al.
BMC Medical Informatics and Decision Making|July 17, 2010
GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypesAiguo Li, Serdar Bozdag, Yuri Kotliarov, et al.
Cancer|September 25, 2014
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to dateJayson I L Bastien, Katharine A McNeill, Howard A Fine
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
World Neurosurgery|February 22, 2021
Foundations of Neuro-Oncology: A Multidisciplinary ApproachMarissa Barbaro, Howard A Fine, Rajiv S Magge
Cornea|June 11, 2009
Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytomaSteven Yeh, Howard A Fine, Janine A Smith
World Neurosurgery|July 10, 2021
Innovations in Neuro-OncologyRajiv S Magge, Marissa Barbaro, Howard A Fine
Cancer Informatics|January 10, 2015
Correction to "master regulators, regulatory networks, and pathways of glioblastoma subtypes"Serdar Bozdag, Aiguo Li, Mehmet Baysan, et al.
Bioinformatics (Oxford, England)|June 2, 2010
FastMEDUSA: a parallelized tool to infer gene regulatory networksSerdar Bozdag, Aiguo Li, Stefan Wuchty, et al.
Neoplasia (New York, N.Y.)|June 26, 2002
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vectorJeongwu Lee, Monika Hampl, Paul Albert, et al.
Journal of Neuro-Oncology|March 28, 2012
Refining endpoints in brain tumor clinical trialsChristina A Meyers, Edwin P Rock, Howard A Fine
Cancer Informatics|November 5, 2014
Master regulators, regulatory networks, and pathways of glioblastoma subtypesSerdar Bozdag, Aiguo Li, Mehmet Baysan, et al.
BMC Medical Informatics and Decision Making|July 17, 2010
GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypesAiguo Li, Serdar Bozdag, Yuri Kotliarov, et al.
Cancer|September 25, 2014
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to dateJayson I L Bastien, Katharine A McNeill, Howard A Fine
Pageof 17